Sort by
Change of Auditor
Change in substantial holding
Change of Director's Interest Notice x2
Cleansing Notice
Application for quotation of securities - PAB
Letter to Shareholders - Annual General Meeting
Notice of Annual General Meeting/Proxy Form
Appendix 4C - Quarterly - 30 September 2026
RLS-2202 Phase 1a Trial Advances to Cohort 2
Investor Presentation
| Date | Headline |
|---|---|
11 Nov 2026 | Change of Auditor |
9 Nov 2026 | Change in substantial holding |
9 Nov 2026 | Change of Director's Interest Notice x2 |
9 Nov 2026 | Cleansing Notice |
9 Nov 2026 | Application for quotation of securities - PAB |
30 Oct 2026 | Letter to Shareholders - Annual General Meeting |
30 Oct 2026 | Notice of Annual General Meeting/Proxy Form |
29 Oct 2026 | Appendix 4C - Quarterly - 30 September 2026 |
22 Oct 2026 | RLS-2202 Phase 1a Trial Advances to Cohort 2 |
13 Oct 2026 | Investor Presentation |